To assess the biological role of E-cadherin loss in prostate cancer progression, we generated the Cdh1L/L:PtenL/L:PB-Cre4 compound mouse model, in which both E-cadherin and Pten deletion co-occur in mouse prostate epithelium. The gene discussed is PTEN; the disease is prostate carcinoma.